Corteva (CTVA) Vylor Investor Day 2026 summary

Strategic transformation, vision, and growth drivers

• Transitioning from a traditional seed seller to a high-margin, IP-driven technology platform, focusing on licensing, hybrid wheat, gene editing, and biofuels as new growth engines over the next decade.

• Launching 12 new technology platforms in corn, soybeans, and wheat by 2035, including the industry's first yield and yield stability trait, multi-disease-resistant corn, and advanced trait stacks, aiming to double annual yield improvement.

• Expanding addressable market beyond traditional row crops through licensing, gene editing, and biofuels, targeting a $75B market by 2035.

• Hybrid wheat platform launching in 2027, targeting $1B revenue by 2040, with global expansion and first U.S. launch in 2027.

• Gene editing positioned as a major future value driver, enabling entry into new crops and markets, with first gene-edited corn hybrids expected later this decade.

Financial framework, guidance, and capital allocation

• Targeting 3%-4% annual revenue growth and 7%-8% EBITDA growth through 2029, with EBITDA margins expanding from 27% to 30% and free cash flow conversion of 60% or better.

• 2026 net sales projected at $10.4B, growing to $11.2–$11.9B by 2029, with $3.3–$3.7B operating EBITDA and licensing income as a key incremental driver.

• Licensing revenue expected to reach $1B by 2035 and $2B by 2040, with a shift from net royalty payer to net royalty earner and net license income approaching $1B by 2035.

• Capital allocation prioritizes R&D (10% of sales), a growing dividend, $1B annual share repurchases (excluding major M&A), and disciplined M&A focused on wheat, gene editing, and adjacent crops.

• Free cash flow conversion targeted at ~60%, with $5.5–$6.5B cumulative FCF from 2027–2029, managed through disciplined inventory planning and balanced capex, dividends, buybacks, and M&A.

Competitive advantages, innovation, and operational excellence

• Deep competitive moat built on proprietary germplasm, global R&D and production footprint, AI-driven breeding and operations, and trusted farmer relationships.

• Industry-leading R&D pipeline with $19B estimated peak net trade revenue value by 2039 and $19 of peak sales revenue per $1 invested.

• Integrated One Seed operating model connects R&D, production, and commercialization, enabling productivity gains and reliable supply.

• AI and automation deployed across R&D and supply chain, generating over $100M in cost savings and accelerating product development.

• Proven management team with deep industry experience and a track record of delivering innovation and growth.